Literature DB >> 8326975

Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action.

I M Spitz1, C W Bardin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8326975     DOI： 10.1056/NEJM199308053290607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  36 in total

Review 1.  Proven and potential clinical applications of mifpristone (RU486).

Authors:  Irving M Spitz
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active.

Authors:  Laura J Lewis-Tuffin; Christine M Jewell; Rachelle J Bienstock; Jennifer B Collins; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

3.  Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.

Authors:  Maxwell N Skor; Erin L Wonder; Masha Kocherginsky; Anju Goyal; Ben A Hall; Yi Cai; Suzanne D Conzen
Journal:  Clin Cancer Res       Date:  2013-09-09       Impact factor: 12.531

Review 4.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

5.  Misoprostol as aid in First Trimester MTP.

Authors:  Shakti Vardhan; R C Behera; G S Sandhu; B K Goyal
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 6.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 7.  A benefit-risk assessment of medical treatment for uterine leiomyomas.

Authors:  Vincenzo De Leo; Giuseppe Morgante; Antonio La Marca; Maria Concetta Musacchio; Massimo Sorace; Chiara Cavicchioli; Felice Petraglia
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Direct effect of glucocorticoids on lipolysis in adipocytes.

Authors:  Chong Xu; Jinhan He; Hongfeng Jiang; Luxia Zu; Wenjie Zhai; Shenshen Pu; Guoheng Xu
Journal:  Mol Endocrinol       Date:  2009-05-14

9.  Mifepristone increases gamma-retroviral infection efficiency by enhancing the integration of virus into the genome of infected cells.

Authors:  V Solodushko; B Fouty
Journal:  Gene Ther       Date:  2010-05-20       Impact factor: 5.250

10.  Luman/CREB3 recruitment factor regulates glucocorticoid receptor activity and is essential for prolactin-mediated maternal instinct.

Authors:  Amanda C Martyn; Elena Choleris; Daniel J Gillis; John N Armstrong; Talya R Amor; Adam R R McCluggage; Patricia V Turner; Genqing Liang; Kimberly Cai; Ray Lu
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.